Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-24

FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ipratropium Bromide and Albuterol Sulfate from Cipla USA Inc., indicating approval of a supplemental change to this …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (ipratropium bromide and albuterol sulfate)

Snippet

SUPPL AP for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)